abstract: WNT/b-catenin signaling has been described as a crucial regulator of embryonic stem cells and embryogenesis. However, little is known on its role during human preimplantation embryo development, besides the RNA expression of its multiple players. In this study, we performed b-catenin loss-and gain-of-function studies on human preimplantation embryos by adding either Cardamonin or GSK3 inhibitor, 1-Azakenpaullone, to the embryo culture medium from the cleavage until blastocyst stages (Days 3-5/6). b-Catenin was displayed in the cortical region underneath the membrane during all stages, but it only showed nuclear localization at cleavage stages after stabilization with 1-Azakenpaullone. We did not observe any effects on the inner cell mass markers NANOG, POU5F1, SOX2 and SALL4 in these functional experiments. However, both b-catenin degradation and stabilization caused inhibition of the trophectoderm (TE) fate, illustrated by KRT18 and GATA3 RNA, and CDX2 protein expression. Based on the TE-specific WNT3 protein expression in blastocysts, we postulated that this protein may be an upstream regulator for the observed membrane b-catenin function. The addition of either WNT3 or 1-Azakenpaullone to the culture medium promoted EOMES expression specific for trophoblast development. In both studies, the canonical WNT pathway target gene, TCF1, was not affected. Therefore, we conclude that WNT3 and membrane-associated b-catenin promote progenitor trophoblast development in human blastocysts. These results have important implications in assisted reproduction and stem cell biology.
Introduction
The balance between totipotency and differentiation during embryo development is regulated by an intricate and yet to be completely understood web of exogenous stimuli (Suwinska and Ciemerych, 2011) . Various members of at least three large protein families, WNT, FGF and TGFb, stimulate a series of intercellular signaling cascades, which frequently cross-react. These immense cross-reactions and multiple signaling pathways make the in-depth understanding of early embryogenesis extremely challenging. Human embryonic stem cells (hESC), which are derived from inner-cell mass (ICM) cells (Thomson et al., 1998; Reubinoff et al., 2000) , represent a potential in vitro model to study early embryogenesis and have previously been cultured specifically to assess the roles of the WNT, FGF and TGFb pathways in long-term cell self-renewal.
Both FGF and TGFb/Activin pathways play crucial roles for the maintenance of the undifferentiated state of hESC in culture (Amit et al., 2000; James et al., 2005; Lu et al., 2006; Xiao et al., 2006; Greber et al., 2008) , largely due to the direct activation of the key pluripotency gene, NANOG (Xu et al., 2008) . However, according to the context, modulators of the same protein families can also hinder the pluripotent capacity of hESC. For instance, supplementation with Activin A and FGF forces endoderm specification (D'Amour et al., 2005; Sui et al., 2012) . FGF, in the presence of BMP4 (another member of TGFb family, which antagonizes Activin A), is essential for the specialization of hESC toward the trophoblast (TB) lineage (Xu et al., 2002; Marchand et al., 2011) . TGFb signaling simultaneously induces the expression of NANOG and the suppression of SOX2, key genes for pluripotency (Greber et al., 2008) . Meanwhile, the inhibition of FGF, TGFb and BMP4 leads to neural induction via downregulation of NANOG and upregulation of SOX2 (Greber et al., 2008) . The TGFb pathway has been proposed to participate downstream of WNT during prolonged culture of hESC (James et al., 2005) . In turn, Activin A can induce FGF and WNT expression in undifferentiated hESC (Xiao et al., 2006) .
Prior knowledge of the WNT signaling pathway has demonstrated that it is rather complex as well. Interacting with FGF and TGFb pathways, WNT proteins are largely responsible for sustaining the fragile balance between pluripotency and differentiation (Dravid et al., 2005; Lu et al., 2006; Sokol, 2011; Van Camp et al., 2014) . Based on the involvement of certain intracellular players, WNT signaling can be divided into either nuclear b-catenin-dependent (canonical) or independent (noncanonical) cascades (Archbold et al., 2012; Van Camp et al., 2014) . GSK3b, an important negative regulator of the WNT pathway, phosphorylates b-catenin, targeting it for degradation (Aberle et al., 1997) . Therefore, deprivation of GSK3b after WNT activation leads to b-catenin stabilization. Consequently, b-catenin is translocated to the nucleus where it activates WNT target genes of canonical pathway, such as TCF1 and LEF1 (Roose et al., 1999; Hovanes et al., 2001; Filali et al., 2002; Archbold et al., 2012) . Activation of the WNT/b-catenin cascade and GSK3b inhibition promotes pluripotency of hESC (Sato et al., 2004; Ying et al., 2008; Wray and Hartmann, 2012) . However, GSK3b also induces differentiation in hESC when POU5F1, an important pluripotency marker, is knocked down (Blauwkamp et al., 2012; Davidson et al., 2012; Singh et al., 2012) . The fact that GSK3b has also been described in noncanonical WNT signaling independently from its role in nuclear b-catenin stabilization (Grumolato et al., 2010) makes its impact on the WNT function in hESC even more complex. The WNT pathway has already been shown to mediate hESC differentiation toward distinct cell types not only at different levels of expression but also at various time points (Blauwkamp et al., 2012) . For instance, high levels of WNT pathway activity are related to endoderm and cardiac differentiation, while low levels are detected during differentiation toward the neural lineage. In the absence of FGF and without additional support of any other factors, the WNT pathway can induce endoderm specification (Bone et al., 2011) and, in its constitutively active state, WNT signaling leads to mesoderm formation in hESC (Sumi et al., 2008) .
b-Catenin has recently been shown to be nonessential for the maintenance of mouse embryonic stem cells (mESC) self-renewal, since embryonic stem cells (ESC) derived from b-catenin-deficient mice retain pluripotent capacity (Lyashenko et al., 2011; Wray et al., 2011) . Nonetheless, b-catenin is still required for the induction of stemness markers in ESC treated with GSK3b inhibitor. Importantly, b-catenin sustains adherent junctions, being an intermediate protein between cadherins and a-catenin connected to the actin cytoskeleton (Kemler, 1993) . Furthermore, it is linked to the noncanonical WNT pathway, establishing cell polarity (Tian et al., 2011; Amin and Vincan, 2012) .
WNT also regulates differentiation in mouse embryos (Tanaka et al., 2011) and is particularly critical in anterior -posterior patterning during mouse gastrulation (Arkell et al., 2013) and in embryoid bodies (ten Berge et al., 2008) . Loss-of-function studies have uncovered an essential role of WNT pathway in the development of the primitive streak (Huelsken et al., 2000; Fu et al., 2009) , while other reports have demonstrated negative effects of b-catenin ablation on mesoderm, definitive endoderm and ectoderm formations (Haegel et al., 1995) .
Based on its ability to balance between intensively proliferating and quiescent differentiating cells, the role for WNT signals has been previously described in various tumors (Clevers and Nusse, 2012; Herr et al., 2012) .
Although multiple members of the WNT pathways have been detected while screening various human embryonic stages for RNA expression (Dobson et al., 2004; Adjaye et al., 2005; Zhang et al., 2009; He et al., 2010; Yan et al., 2013) , little is currently known regarding the role of WNT signaling during human preimplantation development.
Therefore, taking into account the need to broaden the knowledge on regulators of human preimplantation development for assisted reproductive medicine, we chose the key players of WNT pathway as the focus of our investigation.
Materials and Methods

Ethics statement
Human preimplantation embryos were obtained for this study at the Brussels' Centre for Reproductive Medicine (CRG) with the approval of the Institutional Ethics Committee, the Federal Committee for Scientific Research on Embryos in vitro and the couples' written informed consent. Female patients underwent controlled ovarian stimulation followed by oocyte retrieval as previously described elsewhere (Platteau et al., 2003; Kolibianakis et al., 2004) . Oocytes were denuded from their surrounding cumulus and corona cells (Van de Velde et al., 1997) , and those that were mature at that time were injected for the patients' treatment . The fresh and cryopreserved embryos that could not be used for the patients according to the CRG's criteria were made available for descriptive and functional research studies. Cryopreserved embryos could be used after the legally determined period of 5 years, provided that written informed consent was previously obtained from the patients. Additionally Day 3 embryos were created for research using donor oocytes and donor sperm with the permission of both the Local and Federal Ethics Committees, and the donors who were asked to provide informed consent.
Fresh human preimplantation embryos for descriptive studies
Day 3 embryos were created for research using donor oocytes and donor sperm as mentioned above. Later-stage (Days 4-6) embryos were mainly obtained from patients seeking preimplantation genetic diagnosis (PGD) with embryos carrying genetic mutations; these good-quality embryos are known to develop normally after one-cell biopsy and possess high implantation rates that are comparable with conventional intra-cytoplasmic sperm injection (ICSI) embryos (Goossens et al., 2008) (Supplementary data, Fig. S1 ).
All embryos were derived from normally fertilized oocytes (2PN) with good morphology and developmental rates: G1 for the cleavage/compaction stages and blastulation with an A and B score for ICM and trophectoderm (TE) according to Alpha scientists (2011) (Embryology, 2011) . All embryos were cultured individually in 25-ml droplets of either sequential M1 (EmbryoAssist) and M2 (BlastAssist) medium (Medicult, Jyllinge, Denmark) or Q1 (Quinn's Protein Plus Cleavage Medium) and Q2 (Quinn's Advantage Plus Blastocyst Medium) medium (Sage In Vitro Fertilization) under oil (Vitrolife, Sweden) (6% O 2 , 5% CO 2 and 89% N 2 ).
Thawing and culturing of human embryos for functional studies To achieve the largest group possible of simultaneously developing human embryos, we decided to use six-to eight-cell stage, Day 3 human embryos cryopreserved in straws containing 1.5 M dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO, USA) solution buffered with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) as previously described elsewhere (Van Landuyt et al., 2013) (Supplementary data, Fig. S1 ). Embryos were stored in liquid nitrogen. The straws were thawed slowly at a rate of 58C/min, starting from 21008C until +48C. Afterward, the straws were opened, and the embryos were kept at room temperature in a Petri dish containing 1 mol/l sucrose solution buffered with HEPES and supplemented with human albumin [HEPES + Human serum albumin (HSA)]. The embryos were washed initially with HEPES + HSA for 10 min at room temperature and then briefly another two times with HEPES + HSA at 378C. Following this washing procedure, the embryos were transferred into Q2 culture medium.
Dishes containing 25-ml droplets of Q2 medium with drugs either 20 mM 1-Azakenpaullone [A3734, Sigma (Sikes and Bely, 2010; Meyers et al., 2012)] or 20 mM Cardamonin [C8249, Sigma (Cho et al., 2009; Yadav et al., 2012; Jia et al., 2014) ] or with WNT3 protein (100 ng/ml, H00007473-P01, Novus Biologicals, Cambridge, UK) were prepared in advance and left for calibration in the incubator for 4 h. The stock 50 mM solutions of 1-Azakenpaullone and Cardamonin were prepared in DMSO, and the medium in control dishes for these drugs contained equal concentrations of DMSO (1:2500 dilution). The control for the experiment with WNT3 was simple Q2 medium.
Thawed after cryopreservation, six-to eight-cell stage Day 3 human embryos were transferred into individual droplets and cultured until the blastocyst stage on Developmental Day 5/6. We originally tested these drugs with a concentration of 10 mM; however, we did not notice any visible effect (data not shown). Since 1-Azakenpaullone is known to gradually degrade at 378C, drug/ WNT3-containing dishes were refreshed daily. Morphologically identical blastocysts from either the control or drug/WNT3-treated groups were either harvested for real-time quantitative real-time polymerase chain reaction (qRT-PCR) or fixed in formaldehyde to perform immunostaining.
Real-time qRT-PCR
RNA extraction from the single embryos was executed as previously described (Cauffman et al., 2005) . DNAse treatment [RNase-Free DNase Set, 18068015 (Invitrogen, Merelbeke, Belgium)] was performed on all samples. High Capacity RNA-to-cDNA Synthesis Kit with no reverse transcriptase control (4390711, Life Technologies, Gent, Belgium) was used to reverse transcribe isolated RNA. Transcripts in human embryos were quantified by real-time RT-PCR (ViiATM7; Life Technologies). We used TaqMan assays from Life Technologies to detect RNA levels for the following genes:
′ CATCACCTCCACCACCTGG3 ′ , probe GCCTTCTCGCCCCC) were self-designed (Van Haute et al., 2009) . UBC, GAPDH and RPS24 were used as endogenous controls for relative RNA levels quantification.
Indirect immunocytochemistry
Human embryos and hESC were fixed with 3.7% formaldehyde (Merck, VWR International, Belgium) for 10 min at room temperature. Human embryos were individually manipulated in 50-ml droplets in a 96-well plate (Cellstar, Greiner Bio One, USA). The samples were subsequently washed and permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) for 20 min at room temperature. Samples were incubated overnight at 48C with polyclonal rabbit anti-b-catenin Abs (2 mg/ml, ab16051, Abcam, Cambridge, UK), goat anti-WNT3 (2 mg/ml, ab116222, Abcam), rabbit anti-WNT11 Abs (2-10 mg/ml, ab31962, Abcam), mouse anti-CDX2 Abs [1:500 dilution, CDX2-88, BioGenex, Fremont, CA, USA (Niakan and Eggan, 2013) ], mouse anti-ZO-1 Abs (5 mg/ml; 339100, Invitrogen) or goat anti-NANOG Abs (2.5 mg/ml; AF1997, R&D Systems, Abingdon, UK).
Control reactions for nonspecific binding were included in each experiment and carried out by replacing the primary antibodies with either a corresponding rabbit IgG (SC-2027, Life Technologies), mouse IgG1 (SC-2025, Life Technologies) or goat IgG (SC-2028, Life Technologies), using the same concentration as the corresponding primary antibodies (Supplementary data, Figs S2 and S3). The background signal for primary b-catenin, WNT3 and WNT11 antibodies in embryo staining was additionally verified by blocking with the corresponding peptides in 10× concentration of the primary antibodies [ab16377, ab50436, ab28716, Abcam (Supplementary data, Figs 2B and 3B, D) ].
Alexa Fluor 488-conjugated F(ab')2 fragment of chicken anti-rabbit IgG (A21441, Invitrogen), Alexa Fluor 647-conjugated F(ab')2 fragment of goat anti-mouse IgG (A21237, Invitrogen) and Alexa Fluor 488-conjugated F(ab')2 fragment of donkey anti-goat IgG (A11055, Invitrogen) were used as secondary antibodies at a concentration of 10 mg/ml for 1 h at room temperature in the dark. All primary and secondary antibody solutions were prepared in phosphate-buffered saline (PBS) supplemented with 2% bovine serum albumin (BSA) (Sigma-Aldrich). Extensive washing with PBS supplemented with 2% BSA was performed between all steps. After staining, samples were mounted using glass coverslips (24×3×50 mm) in SlowFade Gold antifade reagent with 4 ′ ,6-diamidino-2-phenylindole (DAPI) (Life Technologies). To prevent squeezing of the embryos, small round glass coverslips (Ø, 10 mm) were placed between the coverslips. Confocal scanning microscopy with an Ar-HeNe laser (488/ 647) (IX71 Fluoview 300; Olympus, Belgium) was performed to record the fluorescent images.
The number of cells within the embryo was calculated using ImageJ software based on the guidelines from a previous study (Kuijk et al., 2012) .
Cell culture
HESC cells were cultured in 20% O 2 and 5% CO 2 at 378C in medium with KnockOutTM-DMEM (KO-DMEM, Life Technologies) containing 20% KO-SR (KnockOutTM Serum Replacement, Life Technologies), 2 mM glutamine (Life Technologies), 1% nonessential amino acids (Life Technologies), 1 mM b-mercaptoethanol (Sigma-Aldrich), 4 ng/ml basic fibroblast growth factor (bFGF, Life Technologies) and 1% penicillin/streptomycin (Life Technologies) on mytomycin-inactivated CF1 mouse embryonic fibroblasts (MEF) and were passaged by mechanical dissociation each 5 -6 days. HESC were used at early passages.
The HeLa cell line was cultured at 378C with 5% CO 2 in KnockOutTM-DMEM (KO-DMEM, Life Technologies) containing 10% heat-inactivated fetal calf serum (FCS, Life Technologies), 2 mM L-glutamine (Life Technologies) and 50 mg/ml penicillin/streptomycin (Life Technologies).
Results
Behavior of b-catenin protein in human preimplantation embryos
The presence of a large number of WNT pathway members at the RNA level has been reported during human preimplantation development in vitro (Dobson et al., 2004; Adjaye et al., 2005; Zhang et al., 2009; He et al., 2010; Yan et al., 2013) . Among them were transcripts of GSK3b and b-catenin (confirmed by our unpublished data). Therefore, we decided first to test the possibility that WNT/b-catenin signaling has a function in human embryos. First, we examined the presence of b-catenin in fresh human embryos. The protein was mostly expressed in the cortical region under the membrane of six-and eight-cell stage Day 3 (Fig. 1A-A ′′ and C-C ′′ ) and compacted Day 4 embryos (Fig. 1E) . ′ -different slice of the same embryos as slice K; n ¼ 8). CDX2 (red) protein was nicely localized in the nuclei of TE cells of expanded blastocysts (J, K and K ′ ; n ¼ 8). b-Catenin protein was reduced by exposing embryos to Cardamonin (G-single slice; n ¼ 5); n-the number of embryos. DAPI staining (blue) was used to localize nuclei of the cells. (Fig. 1F, arrows) . In full Day 5 blastocysts, b-catenin was also concentrated in the cortical region, underneath the membrane in both ICM and TE cells (Fig. 1H) . However, the nuclear form of this protein could not be detected in response to the treatment with 1-Azakenpaullone (Fig. 1I) . Day 6 expanded blastocysts, clearly contained the membrane form of b-catenin in all cells (Fig. 1J ) and remained unchanged after exposure to the GSK3b inhibitor as well ( Fig. 1K and K ′ ). At the same time, CDX2
was evident in the nuclei of TE cells, confirming proper TE specification. Therefore, we proposed that nuclear b-catenin is important before blastulation and dispensable during blastulation in humans. In turn, the evident presence of membrane-associated b-catenin is an indication for the possible presence of noncanonical WNT signals at the blastocyst stage.
Unlike the epiblast lineage, the trophectoderm is hampered by the destruction of b-catenin
To further investigate b-catenin function in human preimplantation development, we performed a loss-of-function experiment with another drug, Cardamonin, which induces the degradation of the b-catenin protein (Fig. 1G ). Thawed Day 3 human embryos were cultured until the blastocyst stage in the presence of Cardamonin. b-Catenin appeared to be dispensable for the ability of the embryos to compact and blastulate (Table I, Fig. 2A, Supplementary data, Fig. S4 ). Blastocysts were examined by qRT-PCR on Developmental Days 5 and 6. Gene expression analysis did not uncover any significant changes in the expression of the following pluripotency genes: NANOG, POU5F1, SOX2 and SALL4 (Fig. 2B and D) . TE marker CDX2 was under-expressed in majority of Cardamonin-treated Day 5 blastocysts (n ¼ 6 out of 9; data not shown) when compared with the controls (n ¼ 1 out of 10; data not shown). We also observed downregulation of the TE-specific expression of KRT18 on Day 5 (Fig. 2C) . In turn, other TE markers like CDX2 and GATA3 were not significantly inhibited on Day 6, and the TB marker EOMES (Chen et al., 2013) was not yet expressed in blastocysts (Fig. 2C, E and Fig. 4) . The TE-specific gap junctions marker CX43 and adhesive complex-related CDH1 were unaffected as well ( Fig. 2C and E) .
Previously, we postulated irrelevance of the canonical nuclear b-catenin-dependent signals at blastulation. Therefore, we also decided to measure levels of TCF1, a well-known canonical WNT/b-catenin target gene. The expression levels of TCF1 were not statistically significantly different in drug-treated blastocysts when compared with the control embryos (Fig. 2D) .
To examine further the effect on ICM and TE lineages upon Cardamonin exposure, we performed immunostainings for CDX2 and NANOG proteins on Day 6 blastocysts (Fig. 3A) . Although the ICM lineage represented by NANOG nuclear expression was not affected by the drug, significantly fewer TE cells were positive for CDX2 in those embryos when compared with the controls (Fig. 3A, C and D) .
Therefore, based on its ability to regulate KRT18 and CDX2 expression, we concluded that b-catenin is capable of regulating TE lineage specification in the human blastocyst.
Inhibition of GSK3b is detrimental for the TE but positive for progenitor TB development
We performed a gain-of-function study on Day 3 human embryos that were thawed and cultured until the expanded blastocyst stage in the presence of GSK3b inhibitor 1-Azakenpaullone, which we previously showed to stabilize nuclear b-catenin at the six-and eight-cell stage. Embryo developmental rates and morphology were not significantly different between drug-treated and control groups (Table II, Fig. 2A,  Supplementary data, Fig. S4 ). Day 6 blastocysts were used to analyze the same general markers for undifferentiated ICM and differentiated TE states. Again, we did not observe substantial changes in the expression of the pluripotency genes and TCF1 upon exposure to the GSK3b inhibitor (Fig. 2F) . GATA3 RNA levels were downregulated, while the rest of the TE markers, CDX2 and KRT18, remained unchanged, as were CX43 and CDH1 (Fig. 2G) . Interestingly, the TB marker EOMES was upregulated in 75% of the analyzed blastocysts (n ¼ 3 out of 4) in contrast to 100% (n ¼ 6) of the negative control embryos (Fig. 4) .
Embryos treated with GSK3 inhibitor were analyzed with immunostainings for key ICM and TE markers. We did not reveal any statistically significant differences in NANOG-and CDX2-positive cells due to b-catenin (Fig. 3A, C and D) .
Identification of WNT protein related to the defined b-catenin function
To understand further which of the WNT ligands could possibly be relevant to the b-catenin-dependent phenotypes described earlier, we studied published microarray data describing gene expression profiles in human blastocysts (Adjaye et al., 2005) . Focusing on WNT genes that are abundant in TE versus ICM (WNT1, WNT2B, WNT3, WNT4, WNT5, WNT11), we detected WNT3 and WNT11 transcripts in fresh expanded blastocysts (data not shown). However, we could only detect WNT3 (Fig. 5A ), but not WNT11 (Fig. 5D ) protein expression in expanded Day 6 blastocysts. TE cells were positive for WNT3 protein, whereas ICM cells were negative ( Fig. 5A and E) . During compaction on Day 4, WNT3 appeared in the outer cells, which are the precursors of TE cells (Fig. 5B) . Cleavage stage embryos were negative for WNT3 (Fig. 5C) The developmental rates of compacted embryos on Day 4 (P ¼ 0.1732), blastocysts on Day 5 (P ¼ 0.8914) and full blastocysts on Day 6 (P ¼ 0.4904) were not statistically different based on chi-square test. The total numbers of the embryos diminished from Days 5 to 6, because we collected some of the embryos on Day 5 for real-time qRT-PCR analysis.
marker ZO-1, we detected high concentrations of WNT3 protein on the apical membrane of TE cells of expanded Day 6 blastocysts ( Fig. 5E and E ′ ). Due to the described expression pattern, it is possible that WNT3 specifically regulates the TE fate in human embryos.
WNT3 promotes the progenitor trophoblast lineage differentiation in human blastocysts
We performed another gain-of-function study with the same experimental strategy, only this time thawed Day 3 embryos were cultured in medium supplemented with WNT3 protein. We did not observe significant differences in the morphology of the embryo exposed to WNT3 (Table III , Fig. 6A, Supplementary data, Fig. S4 ). Relative RNA levels of pluripotency markers NANOG, POU5F1, SOX2, SALL4 and canonical WNT target gene TCF1 were not substantially affected in WNT3-treated blastocysts compared with untreated control embryos of the same stage and morphology on Days 5 and 6 ( Fig. 6B and D) . The same situation was observed with markers of the TE fate CDX2, GATA3, KRT18, CX43 and CDH1 ( Fig. 6C and E) . However, expression of the TB-specific marker EOMES was upregulated during embryo culture by WNT3 with 71.4%
(n ¼ 5 out of 7) of blastocysts being positive for EOMES compared with 16.7% (n ¼ 1 out of 6) in the control group (Fig. 4) . Addition of WNT3 to the embryo culture medium did not cause changes in the number of NANOG-and CDX2-positive cells of blastocysts compared with the controls (Fig. 3B-D) .
Therefore, the observed effects on gene expression upon addition of WNT3 to the culture medium resembled those of 1-Azakenpaullone only in terms of upregulation of EOMES expression, indicating progenitor TB development.
Discussion
We report, for the first time, the role of WNT signaling in early human embryogenesis. We found that, in the human blastocyst, both WNT3 and b-catenin are important for TE specification to the trophoblast lineage. Furthermore, we observed canonical WNT-associated nuclear b-catenin only during the early cleavage stages. Therefore, we consider that mainly membrane-associated b-catenin participates in the TE differentiation processes at the human blastocyst stage. Figure 2 Effects from b-catenin inhibition and stabilization on lineages specification during first differentiation in the human blastocyst on Days 5 and 6. Treatment with Cardamonin or 1-Azakenpaullone did not cause any visible morphological differences in embryos compared with control (A). Pluripotency markers NANOG, SOX2, POU5F1 and SALL4 were unaffected on Day 5 (B, n ¼ 9/10) and Day 6 (D, n ¼ 6) Cardamonin-treated blastocysts. KRT18 was downregulated on Day 5 (C), but the rest of the TE markers CDX2 and GATA3 did not change their levels of expression (C and E, n ¼ 3/5 Day 5, n ¼ 6 Day 6). TE-specific gap junctions marker CX43 and adhesive junctions marker CDH1 were not affected as well (C and E). 1-Azakenpaullone treatment did not affect expression of all the same markers, except that it inhibited GATA3 RNA on Day 6 (F and G, n ¼ 6/4). Mann-Whitney statistical analysis was applied.
The mechanisms by which WNT/b-catenin signaling sustains the balance between pluripotency and differentiation have been largely studied in hESC. The canonical WNT/b-catenin signals are depleted in undifferentiated hESC (Dravid et al., 2005; Sumi et al., 2008; Davidson et al., 2012) . This is additionally supported by the fact that b-catenin is concentrated exclusively in the cortical region, underneath the membrane (Ullmann et al., 2007; Sumi et al., 2008) , which is also the case for the intermediate state during hESC derivation from blastocyst ICM cells (O'Leary et al., 2012) . Furthermore, the knockout of POU5F1 in hESC activates canonical WNT/b-catenin signals and is associated with mesoderm lineage differentiation (Davidson et al., 2012) . Similar to WNT-dependent mechanisms in hESC, sustaining pluripotency via membrane-associated b-catenin has also been described in mouse post-implantation epiblast stem cells (mEpiSC) (Kim et al., 2013) . This confirms the resemblance of hESC and mEpiSC cell types, which differ substantially from mESC in their ground state (Tesar et al., 2007) .
Inhibition of GSK3b has been previously used to assess the role of the WNT/b-catenin pathway via pluripotency genes such as NANOG and POU5F1 in both mESC and hESC (Sato et al., 2004; Umehara et al., 2007) . However, only mESC have been thoroughly proved to use canonical b-catenin signals for self-renewal. Multiple WNT proteins have been shown to prevent mESC from differentiation via b-catenin (Hao et al., 2006) . Canonical WNT/b-catenin signals directly promote Nanog expression via TCF3 or POU5F1 in mESC (Pereira et al., 2006; Abu-Remaileh et al., 2010) . The mechanisms by which self-renewal is established vary according to the ESC type, and it seems likely that canonical WNT/b-catenin signals are more relevant for pluripotency in mESC rather that in hESC. The developmental rates of compacted embryos on Day 4 (P ¼ 0.3104), blastocysts on Day 5 (P ¼ 0.8451) and full blastocysts on Day 6 (P ¼ 0.6752) were not statistically different based on chi-square test. The total numbers of the embryos diminished from Days 5 to 6, because we collected some of the embryos on Day 5 for real-time qRT-PCR analysis.
We were unable to detect the presence of nuclear b-catenin during blastulation in ICM and TE cells, suggesting that canonical WNT/ b-catenin signals are also likely irrelevant at the human blastocyst stage. The absence of an effect on the canonical target gene TCF1 in result of both b-catenin degradation and stabilization confirms this assumption. However, we cannot absolutely rule out the possibility of a b-catenin shuttle between the membrane and nucleus, in order to directly regulate gene expression. In turn, we could clearly observe stabilized nuclear b-catenin upon GSK3b inhibition in six-to eight-cell stage human embryos. Taking into account that the early human cleavage stage blastomeres retain full developmental capacity (De Paepe et al., 2014) , we propose that canonical WNT/b-catenin-dependent signals relate to the undifferentiated state on Developmental Day 3 (and, possibly, Days 1 and 2 as well). Human embryonic blastomeres before compaction and ICM cells have previously been shown to express different specific markers (Cauffman et al., 2006; Cauffman et al., 2009; Krivega et al., 2014) , which implies a disparity in their developmental capacity. By describing the different characteristics of the WNT-dependent b-catenin signaling system, we additionally confirmed this hypothesis.
There is a contradiction in the literature regarding the b-catenin expression pattern in mouse embryos. Similar to our findings in humans, mouse blastocysts expose b-catenin protein in the cortical area underneath the membrane and in the cytoplasm, keeping it out of the nucleus through Figure 5 Expression of WNT proteins in human preimplantation embryos. WNT3 was concentrated in TE cells in expanded blastocysts, fresh and thawed after cryopreservation. ICM was negative for WNT3 protein (A, full stack, n ¼ 16). Outer cells of compacted embryos exposed WNT3 on the membrane and in the cytoplasm (B, one slice of the embryo, n ¼ 5). In the eight-cell embryo WNT3 was not present (C, full stack, n ¼ 8). WNT11 was not expressed in the expanded human blastocysts (D, full stack, n ¼ 4). Co-staining of WNT3 with ZO-1 at the expanded blastocyst stage (E, one slice). Magnified view on TE cells of the same embryo (E ′ ). ZO-1 (red) labels tight junctions and WNT3 (green) was concentrated on the outer membrane of TE cells. DAPI (blue) labeled cellular nuclei; n-the number of embryos. Blastocysts normally under-express EOMES on Day 6, which was also the case for the embryos subjected to Cardamonin for 3 days. Upon exposure to 1-Azakenpaullone, 75% of the embryos compared with 0% in the control group were positive for EOMES. Similarly, WNT3 upregulated EOMES with 71.4% of embryos being positive compared with 16.7% in the control group. all the preimplantation stages (Xie et al., 2008) . However, another group using a different experimental approach showed nuclear b-catenin in ICM, but not in TE cells of mouse blastocysts (Wang et al., 2004) .
The function of b-catenin in cellular adhesion is important for lineage specification (Lyashenko et al., 2011) . According to our data, an imbalance of b-catenin protein levels has a negative effect on early TE fate as marked by KRT18, GATA3 and CDX2 in the human blastocyst, whereas b-catenin stabilization has a positive effect on the TB lineage segregation marked by EOMES. In mice, Eomes is essential for TB development and gastrulation (Kimura et al., 1999) . Downregulation of the TE marker GATA3 upon b-catenin stabilization could be possible, because TE genes are normally being taken over by TB-specific expression of EOMES in humans (Chen et al., 2009; Sasaki, 2010) . Moreover, expression levels of TE-specific genes participating in gap (CX43) and adhesive (CDH1) junctions formation were not affected in all three conditions. This potentially implies irrelevance of these types of cell junctions for the observed phenotypes.
Based on its TE-specific pattern of expression, we propose WNT3 to be an upstream regulator of the b-catenin-dependent function in human blastocysts. WNT3 is largely known as an activator of the canonical cascade, while it is also implicated in noncanonical signals (Samarzija et al., 2009; Qiu et al., 2011) . Also, WNT3A has been previously described to promote TB specification in mESC (He et al., 2008) . Importantly, we demonstrated that WNT3 mimics the effect of the GSK3 inhibitor 1-Azakenpaullone in terms of stimulating progenitor TB development in human embryos. Supporting our findings, Wnt3 expression has previously been shown to be critical for Eomes expression in mouse embryos (Barrow et al., 2007) . Moreover, a simultaneous decrease in embryonic Wnt3 and Eomes levels has been associated with implantation failure in mice (Parks et al., 2011) .
One should also mention that GSK3b kinase phosphorylates more than 100 substrates, including b-catenin and the co-receptors of the canonical and noncanonical WNT pathways (Grumolato et al., 2010) . It also plays a central role in non-WNT pathways (e.g. insulin, TGFb, membrane adhesion) (Beurel et al., 2015) . Therefore, the results observed with the GSK3 inhibitor may not be solely attributed to the canonical WNT but also, possibly, due to a cumulative effect of crosstalk and competition between distinct pathways.
Based on our observations, downregulation of b-catenin did not interfere with the morphology of the human embryos. This could be possibly The developmental rates of compacted embryos on Day 4 (P ¼ 0.1568), blastocysts on Day 5 (P ¼ 0.2575) and full blastocysts on Day 6 (P ¼ 0.0678) were not statistically different based on chi-square test. The total numbers of the embryos diminished from Days 5 to 6, because we collected some of the embryos on Day 5 for real-time qRT-PCR analysis. explained by the ability of another member of the same protein family, plakoglobin, to rescue the function of b-catenin (Buxton and Magee, 1992; Fukunaga et al., 2005; Zhou et al., 2007; Lyashenko et al., 2011) . Similar to our observation in human embryos, ablation of b-catenin in mice did not block blastocyst formation (Xie et al., 2008) . However, it did inhibit implantation of mouse embryos. One can also presume that other extracellular factors, such as TGFb and FGF, may compensate for the lack of WNT and b-catenin signals. This assumption is especially interesting if we take into account that upregulation of the FGF pathway is an important step during trophoblast differentiation in hESC (Marchand et al., 2011) .
We believe that the current study will be of particular importance in the field of reproductive and stem cell biology. Understanding the pathways involved in early embryogenesis may help embryologists to regulate development in vitro. One could potentially use various extracellular factors to supplement the culture medium in order to improve abnormal human embryo development in vitro and, consequently, the clinical outcome after in vitro fertilization. The knowledge derived from this study may also be potentially relevant for the evolution of hESC derivation techniques (Van der Jeught et al., 2013) and for a better understanding of the distinct stem cell states (Tesar et al., 2007) .
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